TX-SOFTSERVE
27.10.2020 12:02:04 CET | Business Wire | Press release
SoftServe , a leading digital authority and consulting company and Premier Consulting Partner in the Amazon Web Services (AWS) Partner Network (APN), announces it has achieved AWS SaaS Competency status. The designation recognizes SoftServe’s experience helping organizations design and build Software-as-a-Service (SaaS) and cloud-native solutions on AWS.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005054/en/
In addition to the AWS SaaS Competency designation, SoftServe has also previously achieved AWS Data & Analytics Competency, AWS DevOps Competency, AWS Financial Services Competency, and AWS Retail Competency designations.
“By achieving AWS SaaS Competency status, we are committed to technical proficiency and customer success in the AWS Partner Network, enabling our clients with the most reliable and cost-effective SaaS solutions that are scalable, secure, and globally accessible,” said Andrew Greene - Associate Vice President, Global Partnerships & Alliances at SoftServe. “SoftServe has a proven track record of helping global organizations migrate, design, and build SaaS and cloud-native solutions on AWS through architecture reviews, technology R&D advisory services, security assessments; as well as full scope application migrations, modernizations, re-architectures, and new builds for enterprise and high-tech ISV clients.”
Using AWS and a well-architected multi-account strategy, Gotransverse and SoftServe implemented a multi-tenant SaaS solution to quickly develop and regularly update its customers’ services and components.
“SoftServe was instrumental in supporting our ability to automate the AWS data center creation process where we can go from nothing to a ready-to-provision data center with just a few keystrokes using Terraform and Ansible on top of the AWS API stack,” said Paul Tindall, CTO at Gotransverse. “Prior to this, building a new data center was very manual and error-prone. During this automation process, we were also able to go from self-managing services such as Redis and Elasticsearch to using AWS provided equivalents (Amazon ElastiCache and Amazon Elasticsearch). The development of this capability has more than paid for itself as we have expanded our geographic footprint across the globe with our launches of additional data centers in Australia, Europe, and North America. We look forward to working with SoftServe as we migrate our microservices layer to Amazon Kubernetes Service (Amazon EKS) and explore AWS artificial intelligence (AI) and machine learning (ML) offerings for enhancements to our product.”
AWS enables reliable, scalable, and secure solutions for startups to global enterprises. To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify Consulting and Technology APN Partners with deep industry experience and expertise. AWS SaaS Competency Partners help customers reduce friction when migrating off legacy applications and establish foundations required to build SaaS solutions successfully on AWS. They also write production application code and design and implement end-to-end solutions architecture for cloud-native products on AWS.
SoftServe’s Cloud-enabled services guide you from vision to execution in your SaaS journey, supporting key competencies in streamlined onboarding procedures, identity and access management, tenant isolation, and data partitioning. To learn more about SoftServe’s SaaS offerings on AWS, please visit www.softserveinc.com/en-us/aws-saas-enablement .
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.
SoftServe delivers open innovation—from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience is built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.
Visit our website , blog , LinkedIn , Facebook , and Twitter pages.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201027005054/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release
New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p
Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release
By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release
Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
